留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

孤儿核受体NR4A1与动脉粥样硬化的研究进展

干润 霍炎 黄金路 杨全军 郭澄

干润, 霍炎, 黄金路, 杨全军, 郭澄. 孤儿核受体NR4A1与动脉粥样硬化的研究进展[J]. 药学实践与服务, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
引用本文: 干润, 霍炎, 黄金路, 杨全军, 郭澄. 孤儿核受体NR4A1与动脉粥样硬化的研究进展[J]. 药学实践与服务, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
GAN Run, HUO Yan, HUANG Jinlu, YANG Quanjun, GUO Cheng. Research progress on orphan nuclear receptor NR4A1 in atherosclerosis[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
Citation: GAN Run, HUO Yan, HUANG Jinlu, YANG Quanjun, GUO Cheng. Research progress on orphan nuclear receptor NR4A1 in atherosclerosis[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002

孤儿核受体NR4A1与动脉粥样硬化的研究进展

doi: 10.3969/j.issn.1006-0111.2016.04.002
基金项目: 国家自然科学基金(81503155);上海市科委基金(14ZR1432200);上海交通大学医工交叉项目(YG2014MS21)

Research progress on orphan nuclear receptor NR4A1 in atherosclerosis

  • 摘要: 孤儿核受体NR4A1是尚未发现特异性配体的转录因子之一,属于NR4A亚家族。早期研究发现,NR4A1可通过改变基因表达、翻译后修饰以及辅调蛋白间相互作用,调控细胞的增殖、凋亡、分化和应激反应。近年来研究发现其在动脉粥样硬化损伤部位表达异常,被认为是血管细胞功能紊乱过程中的关键调节基因。通过调控NR4A1基因的表达,可对平滑肌细胞的增殖和内皮细胞的激活产生重要影响,同时能够减少炎症反应、减少泡沫细胞的形成以及脂质沉积,抑制血管重塑,预防和阻止动脉粥样硬化的发生与发展。这些研究显示NR4A1可能成为研发预防和治疗动脉粥样硬化药物的新靶点。
  • [1] Hollman DA, Milona A, van Erpecum KJ, et al. Anti-inflammatory and metabolic actions of FXR:insights into molecular mechanisms[J]. Biochim Biophys Acta, 2012, 1821(11):1443-1452.
    [2] Xiao X, Wang P, Chou KC. Recent progresses in identifying nuclear receptors and their families[J]. Curr Top Med Chem, 2013, 13(10):1192-1200.
    [3] 聂鹏. NR4A孤儿核受体亚家族与动脉粥样硬化[J]. 心血管病学进展,2011,32(5):640-644.
    [4] Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene[J]. Neuron, 1988, 1(3):183-188.
    [5] Baker KD, Shewchuk LM, Kozlova T, et al. The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway[J]. Cell, 2003, 113(6):731-742.
    [6] Wang WJ, Wang Y, Chen HZ, et al. Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway[J]. Nat Chem Biol, 2014, 10(2):133-140.
    [7] Kurakula K, Koenis DS, van Tiel CM, et al. NR4A nuclear receptors are orphans but not lonesome[J]. Biochim Biophys Acta, 2014, 1843(11):2543-2555.
    [8] Libby P. History of discovery:inflammation in atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2012, 32(9):2045-2051.
    [9] de Vries CJM, van Achterberg TAE, Horrevoets AJG, et al. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells:local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes[J]. J Biol Chem, 2000, 275(31):23939-23947.
    [10] Arkenbout EK, de Waard V, van Bragt M, et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis:decreased lesion formation in carotid artery ligation model in TR3 transgenic mice[J]. Circulation, 2002, 106(12):1530-1535.
    [11] Pires NM, Pols TW, de Vries MR, et al. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation[J]. Circulation, 2007, 115(4):493-500.
    [12] Bonta PI, Matlung HL, Vos M, et al. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels[J]. Cardiovasc Res, 2010, 87(3):561-568.
    [13] Kim HJ, Kim JY, Lee SJ, et al. α-Lipoic acid prevents neointimal hyperplasia via induction of p38 mitogen-activated protein kinase/Nur77-mediated apoptosis of vascular smooth muscle cells and accelerates postinjury reendothelialization[J]. Arterioscler Thromb Vasc Biol, 2010, 30(11):2164-2172.
    [14] Cui M, Cai Z, Chu S, et al. Orphan nuclear receptor Nur77 inhibits angiotensin Ⅱ-induced vascular remodeling via downregulation of β-catenin[J]. Hypertension, 2016, 67(1):153-162.
    [15] Yu Y, Cai Z, Cui M, et al. The orphan nuclear receptor Nur77 inhibits low shear stress-induced carotid artery remodeling in mice[J]. Int J Mol Med, 2015, 36(6):1547-1555.
    [16] Bonta PI, van Tiel CM, Vos M, et al. Nuclear orphan receptors Nur77, Nurr1 and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses[J]. Arterioscler Thromb Vasc Biol, 2006, 26(10):2288-2294.
    [17] Pei L, Castrillo A, Chen M, et al. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli[J]. J Biol Chem, 2005, 280(32):29256-29262.
    [18] Pei L, Castrillo A, Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77[J]. Mol Endocrinol, 2006, 20(4):786-794.
    [19] Shao Q, Shen LH, Hu LH, et al. Nuclear receptor Nur77 suppresses inflammatory response dependent on COX-2 in macrophages induced by oxLDL[J]. J Mol Cell Cardiol, 2010, 49(2):304-311.
    [20] Hanna RN, Shaked I, Hubbeling HG, et al. NR4A1(Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis[J]. Circ Res, 2012, 110(3):416-427.
    [21] Hu YW, Zhang P, Yang JY, et al. Nur77 decreases atherosclerosis progression in apoE(-/-) mice fed a high-fat/high-cholesterol diet[J]. PLoS ONE, 2014, 9(1):e87313.
    [22] Gruber F, Hufnagl P, Hofer-Warbinek R, et al. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1(PAI-1) promoter regulates TNF alpha-induced PAI-1 expression[J]. Blood, 2003, 101(8):3042-3048.
    [23] You B, Jiang YY, Chen S, et al. The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of Ikappa Balpha expression[J]. Circ Res, 2009, 104(6):742-749.
    [24] Zeng H, Qin L, Zhao D, et al. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity[J]. J Exp Med, 2006, 203(3):719-729.
    [25] Yang P, Wei X, Zhang J, et al. Antithrombotic effects of Nur77 and Nor1 are mediated through upregulating thrombomodulin expression in endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2015, 36(2):361-369.
    [26] Qin Q, Chen M, Yi B, et al. Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells[J]. J Mol Cell Cardiol, 2014, 77:20-28.
    [27] Zhan Y, Du X, Chen H, et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77[J]. Nat Chem Biol, 2008, 4(9):548-556.
    [28] Huo Y, Yi B, Chen M, et al. Induction of Nur77 by hyperoside inhibits vascular smooth muscle cell proliferation and neointimal formation[J]. Biochem Pharmacol, 2014, 92(4):590-598.
    [29] Pekarsky Y, Hallas C, Palamarchuk A, et al. Akt phosphorylates and regulates the orphan nuclear receptor Nur77[J]. Proc Natl Acad Sci (USA), 2001, 98(7):3690-3694.
    [30] Lee SO, Li X, Hedrick E, et al. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells[J]. Mol Endocrinol, 2014, 28(10):1729-1739.
  • [1] 刘丽艳, 余小翠, 孙传铎.  纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
    [2] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
    [3] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
    [4] 冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军.  雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
    [5] 岳春华, 贲永光, 王海桥.  基于NLRP1炎症小体探讨百合知母汤抗抑郁的作用机制 . 药学实践与服务, 2024, 42(8): 325-333. doi: 10.12206/j.issn.2097-2024.202401033
    [6] 李想, 陆鸿远, 张明玉, 高欢, 姚东, 许子华.  米格列醇激活UCP1介导棕色脂肪对冷暴露小鼠损伤的研究 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202404005
    [7] 刘汝雄, 杨万镇, 涂杰, 盛春泉.  铁死亡调控蛋白GPX4的小分子抑制剂研究进展 . 药学实践与服务, 2024, 42(9): 375-378. doi: 10.12206/j.issn.2097-2024.202312075
    [8] 李丹, 戴贤春, 王芳珍, 陈奕含, 杨萍, 刘继勇.  HPLC-MS/MS测定当归六黄汤中4种不同成分的含量 . 药学实践与服务, 2024, 42(6): 248-252, 266. doi: 10.12206/j.issn.2097-2024.202305007
    [9] 修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星.  全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
    [10] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
    [11] 杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛.  正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
    [12] 张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉.  MT-1207对血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202306011
  • 加载中
计量
  • 文章访问数:  4010
  • HTML全文浏览量:  489
  • PDF下载量:  1050
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-01-28
  • 修回日期:  2016-04-22

孤儿核受体NR4A1与动脉粥样硬化的研究进展

doi: 10.3969/j.issn.1006-0111.2016.04.002
    基金项目:  国家自然科学基金(81503155);上海市科委基金(14ZR1432200);上海交通大学医工交叉项目(YG2014MS21)

摘要: 孤儿核受体NR4A1是尚未发现特异性配体的转录因子之一,属于NR4A亚家族。早期研究发现,NR4A1可通过改变基因表达、翻译后修饰以及辅调蛋白间相互作用,调控细胞的增殖、凋亡、分化和应激反应。近年来研究发现其在动脉粥样硬化损伤部位表达异常,被认为是血管细胞功能紊乱过程中的关键调节基因。通过调控NR4A1基因的表达,可对平滑肌细胞的增殖和内皮细胞的激活产生重要影响,同时能够减少炎症反应、减少泡沫细胞的形成以及脂质沉积,抑制血管重塑,预防和阻止动脉粥样硬化的发生与发展。这些研究显示NR4A1可能成为研发预防和治疗动脉粥样硬化药物的新靶点。

English Abstract

干润, 霍炎, 黄金路, 杨全军, 郭澄. 孤儿核受体NR4A1与动脉粥样硬化的研究进展[J]. 药学实践与服务, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
引用本文: 干润, 霍炎, 黄金路, 杨全军, 郭澄. 孤儿核受体NR4A1与动脉粥样硬化的研究进展[J]. 药学实践与服务, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
GAN Run, HUO Yan, HUANG Jinlu, YANG Quanjun, GUO Cheng. Research progress on orphan nuclear receptor NR4A1 in atherosclerosis[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
Citation: GAN Run, HUO Yan, HUANG Jinlu, YANG Quanjun, GUO Cheng. Research progress on orphan nuclear receptor NR4A1 in atherosclerosis[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
参考文献 (30)

目录

    /

    返回文章
    返回